Serena Vettori

Naples, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Diffuse Cutaneous Systemic Sclerosis Complicated by Serum Amyloid A Protein Cardiac Amyloidosis and Cardiogenic Shock.

Diffuse Cutaneous Systemic Sclerosis Complicated by Serum Amyloid A Protein Cardiac Amyloidosis and Cardiogenic Shock.

Journal: CJC open

Published: October 06, 2025

Progression, Management, and Outcome of Aortic Valve Stenosis in Systemic Sclerosis: A Case Series.

Progression, Management, and Outcome of Aortic Valve Stenosis in Systemic Sclerosis: A Case Series.

Journal: Journal of cardiovascular development and disease

Published: August 05, 2024

Fulminant Myocarditis Unmasking Adult-Onset Still's Disease and Desmoplakin Truncation.

Fulminant Myocarditis Unmasking Adult-Onset Still's Disease and Desmoplakin Truncation.

Journal: Circulation. Cardiovascular imaging

Published: June 07, 2023

Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort.

Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort.

Journal: RMD open

Published: May 18, 2022

Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects.

Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects.

Journal: Respiratory research

Published: March 02, 2022

Effect of Nintedanib on Progression of Systemic Sclerosis-Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial.

Effect of Nintedanib on Progression of Systemic Sclerosis-Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial.

Journal: ACR open rheumatology

Published: February 18, 2022

A phase 2 randomized, double-blinded, placebo-controlled, multicenter trial evaluating the efficacy and safety of raloxifene for patients with mild to moderate COVID-19.

A phase 2 randomized, double-blinded, placebo-controlled, multicenter trial evaluating the efficacy and safety of raloxifene for patients with mild to moderate COVID-19.

Journal: EClinicalMedicine

Published: November 21, 2021

Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database.

Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database.

Journal: Autoimmunity reviews

Published: August 11, 2019

T-Cell Proapoptotic and Antifibrotic Activity Against Autologous Skin Fibroblasts in vitro Is Associated With IL-17A Axis Upregulation in Systemic Sclerosis.

T-Cell Proapoptotic and Antifibrotic Activity Against Autologous Skin Fibroblasts in vitro Is Associated With IL-17A Axis Upregulation in Systemic Sclerosis.

Journal: Frontiers in immunology

Published: August 06, 2019

Prediction of organ involvement and survival in systemic sclerosis patients in the first 5 years from diagnosis.

Prediction of organ involvement and survival in systemic sclerosis patients in the first 5 years from diagnosis.

Journal: Journal of scleroderma and related disorders

Published: April 20, 2019

Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: from dermal fibroblasts of patients with scleroderma to tight skin 1 mouse.

Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: from dermal fibroblasts of patients with scleroderma to tight skin 1 mouse.

Journal: British journal of pharmacology

Published: February 27, 2019

Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort.

Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort.

Journal: Rheumatology (Oxford, England)

Published: January 13, 2019

Showing 1-12 of 56

Last Updated: 09/26/2026